Gentian Diagnostics AS (OSL:GENT) Net Change in Cash : kr3.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Gentian Diagnostics AS's Net Change in Cash for the three months ended in Mar. 2025 was kr4.0 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was kr3.1 Mil.

Gentian Diagnostics AS Net Change in Cash Historical Data

The historical data trend for Gentian Diagnostics AS's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Net Change in Cash Chart

Gentian Diagnostics AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

-13.58

-43.05

-33.34

6.04

-2.91

Gentian Diagnostics AS Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-2.02	-4.61	12.78	-9.06	4.00

Gentian Diagnostics AS Net Change in Cash Calculation

Gentian Diagnostics AS's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	13.457	+	-10.95	+	-4.95	+	-0.462
	=	-2.9

Gentian Diagnostics AS's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 6.591 + -2.005 + -1.282 + 0.7

= 4.0

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gentian Diagnostics AS Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Gentian Diagnostics AS's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Net Change in Cash

Comparable Companies

OSL:LIFE OSL:OBSRV OSL:MEDI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD XAMS:PHIA XSWX:SOON ZBH SHSE:688271 TSE:7733 LSE:SN. ASX:COH

Traded in Other Exchanges

GENTOo:Sweden 6FK:Germany

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.

Gentian Diagnostics AS Headlines